Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Journal Guam.
Press releases published on September 19, 2025
Hydreight Announces Annual General Meeting Results
VANCOUVER, British Columbia, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS, OTC: HYDTF, FSE: SO6) (“Hydreight” or the “Company”), is pleased to announce that at the 2025 Annual General Meeting (“AGM”) virtually held on …
2025 Buying Guide - Best Mushroom Supplement Gummies 2025: Why MushCanyon Mushroom Gummies Are the Clear Winner
Washington DC, Sept. 19, 2025 (GLOBE NEWSWIRE) -- MushCanyon proudly launches the 2025 Buyer’s Guide: Best Mushroom Supplement Gummies, a definitive look at the year’s top functional mushroom chewables for focus, immunity, gut health, and daily energy. As …
Tevogen Commends HHS for Addressing Long COVID, Emphasizes TVGN 489’s Potential Impact for 20 Million Americans
WARREN, N.J., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today expressed its gratitude to the U.S. Department of Health and Human Services (HHS), Secretary Robert F. Kennedy, Jr., and the Trump …
2025 Buying Guide—Best Functional Mushroom Supplement 2025 – Brain, Weight Loss, Gut Health, Energy, -MushCanyon Adaptogens Lineup 2025
washington Dc, Sept. 19, 2025 (GLOBE NEWSWIRE) -- MushCanyon is proud to introduce its 2025 Adaptogens Lineup, a cutting-edge collection of functional mushroom supplements designed to meet the rising demand for natural solutions in brain health, weight …
Kensana Health Lands $120 million from GEM, Fuelling a Global Plant Based Medicine Revolution
NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Kensana Health Inc. (“Kensana”) today announced it has entered into a share subscription facility of up to $120 million with GEM Global Yield LLC SCS ("GEM"), a Luxembourg-based alternative investment group. …
Acarpia Farmaceutici und EarlyHealth Group erweitern ihre Partnerschaft, um den Zugang in CARICOM und Mexiko zu verbessern
MAILAND, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Acarpia Farmaceutici S.r.l., ein italienischer Pharmahersteller, und EarlyHealth Group, ein globaler Pharmadienstleister, haben die Ausweitung ihrer strategischen Partnerschaft bekannt gegeben, um den Zugang zu …
Acarpia Farmaceutici et EarlyHealth Group élargissent leur partenariat afin d’améliorer l’accès à CARICOM et au Mexique
MILAN, 19 sept. 2025 (GLOBE NEWSWIRE) -- Acarpia Farmaceutici S.r.l., un fabricant pharmaceutique italien, et EarlyHealth Group, un prestataire mondial de services pharmaceutiques, ont annoncé l’élargissement de leur partenariat stratégique afin d’ …
Sironax Named to 2025 Endpoints 11 List of the Most Promising Biotech Startups
WALTHAM, Mass., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Sironax, a global clinical-stage biotechnology company dedicated to discovering and developing transformative therapies for age-related degenerative diseases, today announced that Endpoints News has named …
Signature HealthCARE Committed to Proactive Resident Safety with SafeSpace Global Corporation
Knoxville, TN, Sept. 19, 2025 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation (OTCID:SSGC), a global leader in multimodal AI technology, is pleased to announce an expanded partnership with Signature HealthCARE. Signature HealthCARE, a family-based …
CrazyBulk 2025 | D-BAL, Testo-max , Trenorol , Ultimate Stack Legal Steroids Alternatives launch BY CrazyBulk In USA.
new york, Sept. 19, 2025 (GLOBE NEWSWIRE) -- NEW YORK, Sep 19, 2025 The Crazy Bulk launch effective Ultimate stack like D-Bal, Testo-Max, Trenorol line of products are designed as a legal and safer alternative to anabolic steroids. Before you read this …
MomentMD Expands Virtual Clinical Education Platform Amid Growing Provider Shortages and Clinical Rotation Crisis
MomentMD Logo FORT LAUDERDALE, Fla., Sept. 19, 2025 (GLOBE NEWSWIRE) -- MomentMD, the first-of-its-kind digital health company providing virtual clinical education, today announced the expansion of its platform to meet surging demand from medical, nursing, …
Sonnet to Present at the MedInvest Biotech & Pharma Conference
PRINCETON, N.J., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company developing immunotherapeutic drugs targeted to the tumor microenvironment (TME), today announced …
Emergent BioSolutions Secures $29 Million in MCM Product Orders from International Government Partner
GAITHERSBURG, Md., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has secured new purchase orders from an international government partner for a multi-product supply agreement valued at $29 million (USD). The …
NetworkNewsAudio Announces Audio Press Release (APR) on Innovation in Cancer, Rare Disease Treatment Space
AUSTIN, Texas, Sept. 19, 2025 (GLOBE NEWSWIRE) -- via IBN – NetworkNewsAudio announces the Audio Press Release (APR) titled “Innovative Therapeutics Pipeline Positions Industry for Strong Market Growth,” featuring Oncotelic Therapeutics Inc. (OTCQB: OTLC). …
Advanced Biomed Inc. Announces Launch of A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery
[Tainan City], Taiwan, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (Nasdaq: ADVB) (the “Company”, “Advanced Biomed”), a biotechnology company focused on developing and commercializing innovative biomedical products for precision medicine and …
Clearmind Medicine Secures $10 million Securities Purchase Agreement to Explore Strategic Opportunities
Vancouver, Canada, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
Polyrizon Submits Pre-Sub Package to the FDA for PL-14 Allergy Blocker
Ra’anana, Israel, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a biotechnology company focusing on the development of intranasal products, today announced the submission of its full pre-submission (Pre- …
NTA Implant: Solidifying Global Leadership with MDR Certification and Launching a New Era in Implantology
EGOLZWIL, Switzerland, Sept. 19, 2025 (GLOBE NEWSWIRE) -- NTA Implant, a leading brand of the Switzerland-based Pilatus Swiss Dental GmbH, has announced a strategic milestone in its global growth journey by successfully completing the rigorous MDR (Medical …